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Background: Tramadol is an opioid, synthetic analog of codeine and has been used for the treatment of acute or
chronic pain may be abused. In this work, a developed Dispersive liquid liquid microextraction (DLLME) as binary
solvents-based dispersive liquid-liquid microextraction (BS-DLLME) combined with high performance liquid
chromatography (HPLC) with fluorescence detection (FD) was employed for determination of tramadol in the urine
samples. This procedure involves the use of an appropriate mixture of binary extraction solvents (70 μL CHCl3 and
30 μL ethyl acetate) and disperser solvent (600 μL acetone) for the formation of cloudy solution in 5 ml urine sam-
ple comprising tramadol and NaCl (7.5%, w/v). After centrifuging, the small droplets of extraction solvents were
precipitated. In the final step, the HPLC with fluorescence detection was used for determination of tramadol in the
precipitated phase.
Results: Various factors on the efficiency of the proposed procedure were investigated and optimized. The
detection limit (S/N = 3) and quantification limit (S/N = 10) were found 0.2 and 0.9 μg/L, respectively. The relative
standard deviations (RSD) for the extraction of 30 μg L of tramadol was found 4.1% (n = 6). The relative recoveries
of tramadol from urine samples at spiking levels of 10, 30 and 60 μg/L were in the range of 95.6 – 99.6%.
Conclusions: Compared with other methods, this method provides good figures of merit such as good
repeatability, high extraction efficiency, short analysis time, simple procedure and can be used as microextraction
technique for routine analysis in clinical laboratories.
Keywords: Dispersive liquid-liquid microextraction, Tramadol, HPLC, UrineBackground
Tramadol ((±) cis-2-[(dimethylamino) methyl]-1-(3meth-
oxyphenyl) cyclohexanol hydrochloride) is an opioid, syn-
thetic analog of codeine and is not currently classified as a
controlled substance [1-3]. Tramadol has been used since
1977 like other narcotics applied for the treatment of
acute or chronic pain may be abused [4]. In Iran, this drug
is easily available for patient without prescription and
according to annual reports of ministry of health; 350
million tramadol tablets (100 mg) were sold in 2006–2007* Correspondence: v_kiarostami@iau-tnb.ac.ir
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distribution, and reproduction in any mediumand recently, it has become one of the most widely
dispensed analgesics in Iran’s essential drugs list [5,6]. The
extraction of tramadol from biological samples has usually
been carried out by using liquid-liquid extraction (LLE)
and solid phase extraction (SPE) [4,7-9]. However, LLE is
time consuming and requires large amounts of organic
solvent and SPE uses much less than LLE, but can be rela-
tively expensive. Recently, other extraction methods as free
solvent and miniaturized extractions, such as liquid phase
microextraction (LPME) [10,11], solid phase microextrac-
tion (SPME) [12], solvent bar microextraction (SBME)
[13], liquid phase microextraction with back extraction
(LPME-BS) [14], three - phase hollow fiber liquid phase
microextraction (HF-LPME) [15], have successfully beentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited.
Kiarostami et al. DARU Journal of Pharmaceutical Sciences 2014, 22:25 Page 2 of 8
http://www.darujps.com/content/22/1/25developed for determination of tramadol from different
matrices. Dispersive liquid-liquid microextraction (DLLME)
is a miniaturized liquid extraction that was introduced
in 2006 by Rezaee and coworkers [16]. However, in this
method, the selection of extraction solvents is limited to
one type of heavier or lighter extraction solvent than water.
In our previous work, a new method based on DLLME
methodology as binary solvents–based dispersive liquid-
liquid microextraction (BS-DLLME) was developed for
determination of patulin from apple juice samples [17].
In this method, two kinds of extraction solvents (mix-
ture of low and high density solvents) can be used simul-
taneously. In the present study, a rapid, sensitive and
simple BS-DLLME and high performance liquid chro-
matography coupled with florescence detection has been
carried out for the extraction and pre-concentration of
tramadol in urine samples.
Methods
Reagent
HPLC-grade methanol, acetonitrile, acetone, chloroform,
analytical grade ethyl acetate and deionized water were ob-
tained from Merck chemical co (Darmstadt, Germany).
Carbon tetrachloride (CCl4) with grade of trace analysis
was obtained from Merck. The pure substances of trama-
dol were kindly gifted by Grünenthal chemical co (Stolberg,
Germany). Phosphoric acid, sodium hydroxide and sodium
chloride were all of analytical grade from Merck and were
used without further purification. All the glassware used in
experiments first washed with HPLC grade water and acet-
one and then dried in an oven. For calibration studies,
blank urine samples were kindly obtained from one female
healthy volunteer in our lab which not exposed to the
mentioned drug. The use of tramadol in healthy subjects
has been approved in Tehran University of Medical Sci-
ences ethics committee (Ethics board code 4233).
For recovery studies, fresh urine samples from three
male volunteers with abuse of tramadol were kindly pro-
vided by the Loghman hospital (Tehran, Iran). The study
of tramadol pharmacokinetics in drug abused subjects
has been approved in Tehran University of Medical Sci-
ences ethics committee (Ethics board code 20324).
Standard solution of tramadol in concentration of 1 mg/
mL was prepared by dissolving 10 mg of this compound
in 10 mL HPLC-grade water. Working standard solutions
of tramadol were prepared by dilution of the stock solu-
tion using HPLC-grade water. Stock and standard solu-
tions of this compound were stored at 4°C.
Instrumentation
For separating and analyzing the drug a WellChrom HPLC
instrument from Knauer Company (Berlin, Germany) was
applied. The chromatographic apparatus equipped with a
fluorescence RF-10AXL detector (excitation wavelength of200 nm and emission wavelengths of 301 nm). Gradient
HPLC K-1001 pump and online K-5020 degasser. A Rheo-
dyne model 7725i injector with a 20 μL loop was applied
to inject the samples. Chromatographic data were ac-
quired and analyzed using ChromGate Chromatography
Software from Knauer Company. Separation was carried
out on a ChromolithTM Performance RP-18e, 100 mm×
4.6 mm column (Merck, Darmstadt, Germany) protected
by a ChromolithTM Guard Cartridge RP-18e 5 mm ×
4.6 mm. A mixture of water and methanol (81:19 v/v)
adjusted to pH 2.5 by phosphoric acid at a flow rate of
2 mL/min in isocratic elution mode was used as a mobile
phase. Eppendorf centrifuge 4515c (Netheler-Hinz GMBH
Germany) was used for sedimentation of the dispersive
phase.
Sample preparation
Standard solutions containing 100 μg/mL of tramadol
was prepared in HPLC grade water at (4°C) and brought
to room temperature just prior to use. The pH of urine
sample containing 100 μg/mL tramadol (spiked urine
sample) at pH = 10 by addition of 5 M NaOH. Then
5 mL of this sample was placed in centrifuge tube, after
centrifugation at 1133 × g for 10 min, upper solution
was separated from sediment and was transferred to a
10 mL glass test tube [18].
BS-DLLME procedure A mixture of a disperser solvent
and binary extraction solvents (ethyl acetate and chloro-
form) were injected rapidly into the mentioned pre-
treated urine solution (5 ml) by 1.00 mL syringe and
immediately a cloudy solution was formed. After centri-
fuging the cloudy solution for 10 min at 1133 × g, the
dispersed fine droplets of ethyl acetate and chloroform
were settled in the bottom of conical test tube. The de-
posited phase was transferred to another glass tube and
evaporated to dryness under a gentle air stream. The
residue was dissolved in 70 μL mobile phase and 20 μL
was injected into the HPLC with fluorescence detection
system for analysis.
Results and Discussion
In order to optimize the BS-DLLME for determination
of tramadol in urine samples, the effective parameters
on extraction efficiency such as the type and volume of
high density extraction solvent, the volume of ethyl acet-
ate as low density extraction solvent, the type and vol-
ume of disperser solvent, salt addition and extraction
time were studied. Statistical calculations (single factor
analysis of variance and unpaired t-test) carried out with
Microsoft® excel 2007 for comparing of data. Significant
difference was pretended if the probability level (p) was






















Figure 1 Effect of high density extraction solvent type on the extraction efficiency. Extraction condition: tramadol concentration,
100 μg/ L; volume of extraction solvent, 50 μL; disperser solvent and its volume, 0.6 mL acetonitrile; no salt addition.
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Selection of high density extraction solvent is very im-
portant in BS-DLLME procedure. For this purpose
chloroform (CHCl3, density 1.49 g/L), carbon tetrach-
loride (CCl4, density 1.59 g/ml) and dichloromethane
(CH2Cl2, density 1.32 gmL
−1) selected in this study. A
series of urine samples were surveyed by using 0.6 mL
of acetone (as disperser solvent) contains 70 μL of differ-
ent high density extraction solvents. In the presence of
dichloromethane as extraction solvent, no droplet was
formed and therefore ignored as extraction solvent. As
shown in Figure 1, chloroform has better extraction re-






















Figure 2 Effect of volume of chloroform on the extraction efficiency.
solvent and its volume, 0.6 mL acetonitrile; extraction solvent, chloroform; nunequal variances, p < 0.05) than the other tested sol-
vents. Therefore, CHCl3 was selected as the extraction
solvent in subsequent experiments.
Effect of extraction solvent volume
To examine the effect of high density extraction solvent
volume on performance of the presented BS-DLLME
procedure, we used acetone with a constant volume
(0.6 mL) and different volume of CHCl3 (30–80 μL). As
indicated in Figure 2, the extraction efficiency increases
with CHCl3 volume from 40 to 70 μL. Above 70 μL of
chloroform, the recovery decreases probably due to de-
crease in the number of droplets available for extraction.0 60 70 80
e of chloroform(  l)
Extraction condition: tramadol concentration, 100 μg/L; disperser
o salt addition.
Figure 3 Effect of ethyl acetate volume on the extraction efficiency. Extraction condition: tramadol concentration, 100 μg/ L; extraction
solvent and its volume, 70 μL chloroform; disperser solvent and its volume, 0.6 mL acetonitrile; no salt addition.
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markable effect (single factor analysis of variance, p <
0.05) was selected as the optimal extraction solvent vol-
ume in the BS-DLLME procedure.Effect of ethyl acetate and its volume
The effect of ethyl acetate (C4H8O2 , density 0.897 g /ml)
as lighter extraction solvent in BS-DLLME of tramadol in
urine samples was studied. For considering the influence
of ethyl acetate volume on extraction efficiency, different
volumes of ethyl acetate (0 – 40 μL), fixed volumes of
chloroform (70 μL) and acetonitrile (600 μL) were used
for BS-DLLME procedure. As can be seen in Figure 3, ini-
tially the extraction efficiency increased and then de-
creased by increasing the volume of ethyl acetate. Thus
30 μL of ethyl acetate as lighter density extraction solvent
with lower error bar and 70 μL of chloroform as higherFigure 4 Effect of disperser solvent type on the extraction efficiency.
extraction solvents and their volume, 100 μL mixture of ethyl acetate and cdensity extraction solvent (100 μL of binary extraction sol-
vents) were selected in the subsequent experiments.Selection of disperser solvent
The most important factor affecting the selection on dis-
perser solvent is relative miscibility of the disperser solv-
ent with the binary extraction solvents and aqueous
phase. Methanol, ethanol, acetonitrile and acetone ex-
hibit adequate properties and were studied as disperser
solvents. Then, the effect of these solvents on perform-
ance of BS-DLLME was investigated. For these purpose,
600 μL of disperser solvent and 100 μL of binary extrac-
tion solvents were used. In ethanol and methanol, whit-
ish sediment was formed, which cannot be separated
from supernatant. Thus, the sediment is interfered for
analysis and therefore methanol and ethanol were ig-
nored as disperser solvents. According to Figure 4,Extraction condition: tramadol concentration, 100 μg/L; binary
hloroform (3:7 v/v); disperser solvent volume, 0.6 mL; no salt addition.
Figure 5 Effect of disperser solvent volume on the extraction efficiency. Extraction condition: tramadol concentration, 100 μg/ L; binary
extraction solvents and their volume, 100 μL mixture of ethyl acetate and chloroform (3:7 v/v); disperser solvent, acetone; no salt addition.
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nificant effect (one-tailed unpaired t-test, p < 0.05) and
was chosen as disperser solvent in the following
experiments.Effect of disperser solvent volume
Effect of acetone (as disperser solvent) volume surveyed
by using various volumes of acetone (400 – 1600 μL),
while all experimental condition were kept constant
(100 μL binary extraction solvents). As shown in Figure 5,
the extraction efficiency increased by increasing the
acetone volumes from 400 μL 600 μL. Above 600 μL of
acetone the extraction efficiency decreased for trama-
dol, probably due to increase of tramadol solubility in
the higher volume of acetone. Therefore 600 μL of acet-
one with significant effect (single factor analysis ofFigure 6 Effect of salt addition on the extraction efficiency. Extraction
solvents and their volume, 100 μL mixture of ethyl acetate and chloroformvariance, p < 0.05) was selected as the optimal disperser
solvent volume in BS-DLLME procedure.Effect of salt addition
To evaluate the effect of salt addition on BS-DLLME
performance, various experiments were performed by
adding different amounts of NaCl (0 - 10%, w/v). Adding
of salt may have different results in DLLME like in-
creasing [19], reducing [20] and no impact on recovery
[17]. In this study as indicated in Figure 6, by adding
(0-10%, w/v) NaCl, initially, increasing the NaCl con-
centration to 7.5%, the extraction efficiency increased
then decreased by increasing the NaCl concentration.
Thus, 7.5% (w/v) NaCl with significant effect (single
factor analysis of variance, p < 0.05) was selected for
further experiments.conditions: tramadol concentration, 100 μg/L; binary extraction
(3:7 v/v); disperser solvent and its volume, 0.6 mL acetone.
Figure 7 Effect of extraction time on the extraction efficiency. Extraction conditions: tramadol concentration, 100 μg/L; binary extraction
solvents and their volume, 100 μL mixture of ethyl acetate and chloroform (3:7 v/v); disperser solvent and its volume, 0.6 mL acetone; 7.5% NaCl.
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In DLLME, extraction time is defined as the interval be-
tween injection of the mixture of organic solvents and
centrifugation [21]. Generally extraction time has no im-
pact on DLLME procedure [22]. As shown in Figure 7,
the effect of extraction time on the extraction efficiency
in the range of 0 – 60 min was investigated. The results
showed that, the extraction time had no remarkable ef-
fect (single factor analysis of variance, p > 0.05) on BS-
DLLME procedure.
Overall, according to optimum condition, the values of
studied factors were as follows: 0.6 mL acetone as dis-
perser solvent, 100 μL binary extraction solvents (70 μL
of chloroform and 30 μL of ethyl acetate) and 7.5% (w/v)
NaCl.Table 2 Relative recoveries of tramadol in urine samplesAnalytical performance
Under optimization condition using blank urine samples
spiked at various concentration of tramadol, the charac-
teristic calibration data were obtained. As can be seen in
Table 1, linearity was observed for tramadol in the range
of 1–130 ng/ml with the determination coefficient (r2) of
0.993. The enrichment factor for tramadol was obtained
71.42. The limit of quantification (LOQ, S/N = 10) and
limit of detection (LOD, S/N = 3) were 0.9 and 0.2 ng/ml,Table 1 Figures of merit in the BS-DLLME










Tramadol 0.993 Y = 78382x +
24663




dLinear dynamic range.respectively. The relative standard deviation (RSD) deter-
mined by six replicate experiments was 4.1 at a concentra-
tion of 30 ng/ml.Application in real sample
The applicability of proposed BS-DLLME method was
evaluated for the analysis of different urine samples,
which collected from the patient volunteers under treat-
ment in Baharloo hospital (Tehran, Iran) without any di-
lution. The pH of urine samples was adjusted at 10 by
dropwise addition of 5 M NaOH. The relative recoveries
of tramadol from urine samples were determined at
spiking level of 10, 30 and 60 ng/ml. As can be seen in
Table 2, the results of six replicate experiments of each
sample using the BS-DLLME method are in the range of
95.6 – 99.6%. Thus the proposed method can be applied
for the determination of tramadol in urine samples.
Representative chromatograms with good resolution
obtained for tramadol, from blank human urine sample
(healthy volunteer) and urine sample (volunteer with
abuse of tramadol) spiked with tramadol under the






mean ± SDb/μg/ L
Relative
recovery
Urine nda 10 9.96 ± 0.2 99.6
30 28.67 ± 1.5 95.6
60 59.03 ± 3.48 98.4
Extraction conditions: binary extraction solvents and their volume, 100 μL
mixture of ethyl acetate and chloroform (3:7 v/v); disperser solvent and its
volume, 0.6 mL acetone; 7.5% NaCl.
aNot detected.
bStandard deviation.
Figure 8 Chromatograms for the analysis of tramadol in urine samples. (a) HPLC chromatogram of the urine sample (volunteer with abuse
of tramadol) spiked with tramadol at concentration level 60 μg/ Lafter employing BS-DLLME, (b) HPLC chromatogram of blank human urine
sample (healthy volunteer) after performing BS-DLLME. Extraction conditions: tramadol concentration, 100 μg/L; binary extraction solvents and
their volume, 100 μL mixture of ethyl acetate and chloroform (3:7 v/v); disperser solvent and its volume, 0.6 mL acetone; 7.5% NaCl.
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The figures of merit of BS-DLLME method for deter-
mination of tramadol in urine sample have been com-
pared to earlier reported methods. As shown in Table 3,
the proposed method has lower LOQ, good linear dy-
namic range (LDR) and higher relative recoveries in
comparison to earlier methods. In addition, the extrac-
tion time in BS-DLLME is shorter and this method does
not involve any labor-intensive and time consuming
steps. Determination of tramadol at low levels in plasma
is also important for the pharmacokinetic analysis [23]
and therefore, DLLME procedure can be used as an al-
ternative procedure for the previous analytical methods.Table 3 Comparison of the proposed method with other met
Method Sample matrix RRa, % LD
HPLC-FLb, HPLC-MS/MS Dog urine 82
Liquid extraction HPLC Human plasma 74.7-80.8
SPEc/GC-MS Human oral fluid 87.7
MISPEd/HPLC-UV Human plasma, urine >91
LLE-ion pair formation Urine - 100
BS-DLLME/HPLC-FL Human urine 95.6-99.6
aRelative recovery.
bHigh performance liquid chromatography with fluorescence Detection.
cSolid-phase extraction.
dMolecularly imprinted solid-phase extraction.
eRefferences.Conclusions
The present study has proposed a new method for de-
termination of tramadol in urine samples using the
BS-DLLME coupled with HPLC-fluorescence detection.
BS-DLLME method provides good repeatability and higher
recoveries within a short time. The comparison of this
method with others demonstrated that BS-DLLME was
very fast, simple and inexpensive with good figures of
merit. In comparison to conventional DLLME, the selec-
tion of extraction solvents in BS-DLLME is not limited to
high density solvents. In summary, the developed method-
ology shows good performance of analytical protocol, ex-
hibits excellent recoveries for tramadol in urine samples.hods for the extraction of tramadol
R/μg/ L LOD/μg/ L LOQ/μg/ L r2 Refe.
1-1000 5 10 0.999 [24]
2.5-500 - 2.5 0.997 [25]
10-100 - 10 0.999 [9]
2-300 1.2 3.5 - [4]
00-50000 400 1200 0.997 [26]
1-130 0.2 0.9 0.993 This work
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